tiprankstipranks
Bionexus Gene Lab Corporation (BGLC)
:BGLC
US Market

BioNexus Gene Lab Corp (BGLC) Income Statement

Compare
64 Followers

BioNexus Gene Lab Corp Income Statement

Last quarter (Q3 2024), BioNexus Gene Lab Corp's total revenue was $2.63M, an increase of 3.00% from the same quarter last year. In Q3, BioNexus Gene Lab Corp's net income was $-1.35M. See BioNexus Gene Lab Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 9.77M$ 10.93M$ 13.36M$ 11.39M$ 126.95K
Gross Profit
$ 1.33M$ 1.26M$ 2.19M$ 1.72M$ 55.89K
Operating Expenses
$ 3.92M$ 1.55M$ 1.14M$ 446.00K$ 331.59K
Depreciation and Amortization
$ 108.42K$ 105.42K$ 108.22K$ 101.60K$ 53.33K
EBITDA
$ -2.49M$ -185.76K$ 1.16M$ 1.38M$ -222.37K
Operating Income
$ -2.59M$ -291.18K$ 1.06M$ 1.27M$ -275.70K
Other Income/Expenses
$ -13.93K$ -12.48K$ -12.97K$ -11.31K$ 0.00
Pretax Income
$ -2.61M$ -303.66K$ 1.04M$ 1.26M$ -275.70K
Net Income
$ -2.63M$ -355.97K$ 751.57K$ 1.09M$ -246.47K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.17$ -0.02$ 0.05$ 0.13$ -0.03
Diluted EPS
$ -0.17$ -0.02$ 0.05$ 0.13$ -0.03
Weighted Average Shares Outstanding
15.88M 14.41M 14.27M 8.58M 7.20M
Weighted Average Shares Outstanding (Diluted)
15.88M 14.41M 14.27M 8.58M 7.20M
Currency in USD

BioNexus Gene Lab Corp Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis